BRIACELL THERAPEUTICS CORP (BCT.CA) Stock Analyst Ratings
Canada - TSX:BCT - CA1079303071 - Common Stock
13.75 CAD
-0.35 (-2.48%)
ChartMill assigns a Buy % Consensus number of 80% to BCT.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
BCT.CA was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about BCT.CA.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed BCT.CA. So this is just the average opinion of a couple of analysts.
BRIACELL THERAPEUTICS CORP / BCT.CA FAQ
Can you provide the consensus rating for BRIACELL THERAPEUTICS CORP stock?
The consensus rating for BRIACELL THERAPEUTICS CORP (BCT.CA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for BCT stock?
The number of analysts covering BRIACELL THERAPEUTICS CORP (BCT.CA) is 5.